Cargando…
Interpretable Machine Learning on Metabolomics Data Reveals Biomarkers for Parkinson’s Disease
[Image: see text] The use of machine learning (ML) with metabolomics provides opportunities for the early diagnosis of disease. However, the accuracy of ML and extent of information obtained from metabolomics can be limited owing to challenges associated with interpreting disease prediction models a...
Autores principales: | Zhang, J. Diana, Xue, Chonghua, Kolachalama, Vijaya B., Donald, William A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214508/ https://www.ncbi.nlm.nih.gov/pubmed/37252351 http://dx.doi.org/10.1021/acscentsci.2c01468 |
Ejemplares similares
-
Machine learning and pre-medical education
por: Kolachalama, Vijaya B.
Publicado: (2022) -
Machine learning and medical education
por: Kolachalama, Vijaya B., et al.
Publicado: (2018) -
Detection of dementia on voice recordings using deep learning: a Framingham Heart Study
por: Xue, Chonghua, et al.
Publicado: (2021) -
Interpretation
of the DOME Recommendations for Machine
Learning in Proteomics and Metabolomics
por: Palmblad, Magnus, et al.
Publicado: (2022) -
Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification
por: Qiu, Shangran, et al.
Publicado: (2020)